Related Experiment Video
Updated: May 19, 2026

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
Cancer pain part 1: causes and classification
1Clinical Services Division, The Royal Marsden NHS Foundation Trust, London. suzanne.chapman@rmh.nhs.uk
Abstract:
Pain is a significant problem in patients with cancer. Understanding the causes and types of cancer pain, thorough pain assessment and use of individualised pain management strategies can help to improve quality of care and pain relief for patients with cancer This article provides an overview of cancer pain and the effects this may have on patients and their carers. The nurse's role in understanding pain and interventions that may help to minimise pain are discussed. Assessment and management of cancer pain will be explored in a subsequent article.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis